The discovery that RNA has a variety of biological functions in living organisms [1][2][3] has prompted the development of new methods to elucidate its structure and mechanism at the atomic level. X-ray crystallography is the method of choice for the elucidation of the three-dimensional structure of RNA macromolecules. [4,5] New developments in RNA X-ray crystallography have occurred due to advances in synchrotron radiation, diffraction data collection, [6,7] solid-phase synthesis of RNA oligonucleotides, [8] RNA crystallization, [9,10] and heavy-atom derivatization.[11] To further advance the field of RNA structure and function research, we have been working on the development of selenium derivatization for nucleic acid biochemistry and structure studies. [12][13][14][15][16][17] The use of selenomethionyl proteins for multiwavelength anomalous-dispersion (MAD) phasing has revolutionized the field of protein X-ray crystallography. [18,19] This derivatization of proteins with Se has also been applied successfully in RNA structure determination through indirect derivatization of RNA that binds to the Se-derivatized protein.[11] Motivated by the phosphoroselenoate oligonucleotide structure and function studies with MAD phasing performed by Egli and co-workers, [20] we are developing the enzymatic synthesis of phosphoroselenoate nucleic acids for X-ray crystal structure studies. We report herein the first enzymatic synthesis of phosphoroselenoate RNA (Scheme 1), containing a selenium atom that replaces one of the nonbridging oxygen atoms on the phosphate group, by in vitro transcription with T7 RNA polymerase and adenosine 5'-(a-P-seleno)triphosphate (ATPaSe).For this enzymatic synthesis, we first synthesized and characterized both diastereomeric monomers of adenosine triphosphate harboring the selenium functionality at the a-phosphate group (ATPaSe, Scheme 1) by using a modification of the procedures for the synthesis of nucleotide 5'-(a-Pthio)triphosphates (NTPaS) [21] and thymidine 5'-(a-P-seleno)triphosphate (TTPaSe).[17] The fast-and slow-moving ATPaSe isomers as represented by peaks on the reversedphase (RP) HPLC profile were termed ATPaSe I and ATPaSe II, respectively. A DNA template (55 nucleotides) was designed to allow the incorporation of 12 A residues (Figure 1 a). The generated RNA transcript (35 nucleotides) was body-labeled by using a-[32 P]-cytidine 5'-triphosphate (a-[ 32 P]CTP) in the enzymatic reaction mixture for gel electrophoresis and autoradiography. We first tested the incorporation of ATPaSe I and ATPaSe II. The results (Figure 1 b) indicated that ATPaSe I was incorporated into the RNA transcript as well as natural ATP; however, no full-length product was detected when ATPaSe II was used. Although the formation of short abortive fragments in in vitro transcription is normal, [22] surprisingly, ATPaSe I, which generated almost no short abortive sequences, led to a much cleaner reaction than natural ATP. A mixture of ATP and ATPaSe I also reduced the formation of nondesired short abortive sequ...